HomeInsights52 Week Low Stocks

Genomic Valley Biotech Ltd 52 Week Low

Genomic Valley Biotech Ltd 52 Week Low

stocks purchased

₹ 0.1 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

6.5 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Genomic Valley Biotech Ltd

NSE: GENOMICVALLEY

YEARLOW

₹ 22.36

Last updated on: Nov 22, 2024

Key Highlights

  • The 52 Week Low of Genomic Valley Biotech Ltd is ₹ 22.36 as of 22 Nov 24 .

Company Fundamentals for Genomic Valley Biotech Ltd

No data available

Market Price of Genomic Valley Biotech Ltd

1M

1Y

3Y

5Y

Monitoring Genomic Valley Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 202498.35
21 Nov 2024100.35
19 Nov 202498.5
18 Nov 202498.5
14 Nov 202498
13 Nov 202497.45
12 Nov 202498.95
11 Nov 2024100.95
08 Nov 2024103
07 Nov 2024105

Asset Value vs Market Value of Genomic Valley Biotech Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Genomic Valley Biotech Ltd

No data available

* All values are in crore

Historical Net Profit of Genomic Valley Biotech Ltd

No data available

* All values are in crore

Genomic Valley Biotech Ltd News Hub

News

Genomic Valley Biotech to discuss results

Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 7 O...

Read more

03 Oct 202415:54

News

Genomic Valley Biotech to convene board meeting

Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 29 ...

Read more

24 Jul 202410:21

News

Genomic Valley Biotech schedules board meeting

Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 9 M...

Read more

04 May 202410:44

News

Genomic Valley Biotech revises board meeting date

Genomic Valley Biotech has revised the meeting of the Board of Directors which was schedul...

Read more

13 Feb 202411:55

News

Genomic Valley Biotech revises board meeting date

Genomic Valley Biotech has revised the meeting of the Board of Directors which was schedul...

Read more

12 Feb 202411:56

News

Genomic Valley Biotech to conduct board meeting

Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 10 ...

Read more

05 Feb 202414:17

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Genomic Valley Biotech Ltd

Why is it important to track the 52-week low of Genomic Valley Biotech Ltd stocks?

Investors should monitor the 52-week low of Genomic Valley Biotech Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Genomic Valley Biotech Ltd stocks hitting a 52-week low?

Factors leading to Genomic Valley Biotech Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Genomic Valley Biotech Ltd stocks when they hit a 52-week low?

Buying Genomic Valley Biotech Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Genomic Valley Biotech Ltd stocks?

Investors should monitor the 52-week low of Genomic Valley Biotech Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Genomic Valley Biotech Ltd stock at their 52-week low?

An investor can analyze the reasons for the Genomic Valley Biotech Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Genomic Valley Biotech Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Genomic Valley Biotech Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Genomic Valley Biotech Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*